✦ LIBER ✦

MDM2 and MDM4: p53 regulators as targets in anticancer therapy

✍ Scribed by Franck Toledo; Geoffrey M. Wahl

Book ID: 116307383
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 274 KB
Volume: 39
Category: Article
ISSN: 1357-2725
DOI: 10.1016/j.biocel.2007.03.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular Pathways: Targeting Mdm2 and M

Molecular Pathways: Targeting Mdm2 and Mdm4 in Cancer Therapy

✍ Li, Q.; Lozano, G. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 506 KB

Mdm2 and MdmX partner to regulate p53

✍ Xinjiang Wang; Xuejun Jiang 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 406 KB

Keeping p53 in check: essential and syne

Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4

✍ Marine, J-C; Francoz, S; Maetens, M; Wahl, G; Toledo, F; Lozano, G 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 118 KB

MDM2, MDMX and p53 in oncogenesis and ca

MDM2, MDMX and p53 in oncogenesis and cancer therapy

✍ Wade, Mark; Li, Yao-Cheng; Wahl, Geoffrey M. 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 453 KB

Small molecule agents targeting the p53-

Small molecule agents targeting the p53-MDM2 pathway for cancer therapy

✍ Weisi Wang; Yongzhou Hu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 494 KB

## Abstract The powerful tumor suppressor p53 takes charge of a regulatory network to guard over the living cells from harmful effect of different forms of stress and eradicate the tumor cells for normal physiological condition maintenance. However the antitumor function of p53 is often attenuated

A mouse p53 mutant lacking the proline-r

A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network

✍ Franck Toledo; Kurt A. Krummel; Crystal J. Lee; Chung-Wen Liu; Luo-Wei Rodewald; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 989 KB